<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1538973079464292&amp;ev=PageView&amp;noscript=1">
MENU
Search

What are you looking for?

    Timothy Sellati, P.h.D.

    Chief Scientific Officer at Global Lyme Alliance

    Timothy J. Sellati, PH.D. is Chief Scientific Officer at Global Lyme Alliance As GLA’s Chief Scientific Officer, Dr. Sellati leads GLA’s research initiatives to accelerate the development of more effective methods of diagnosis and treatment of Lyme and other tick-borne diseases.

    Articles

    So, Exactly How Prevalent is Lyme Disease Across the Globe?
    June 29, 2022
    A recent article written for Today.com went viral after the title stated, "Lyme disease has infected over 14% of world population, new study finds." In this article, GLA's Chief Scientific Officer wil...
    Read More
    Lyme Disease and Bell’s Palsy: New Considerations for Differential Diagnosis
    March 28, 2022
    Read More
    Hygromycin A May Prevent Cases of Post-Treatment and Chronic Lyme Disease
    October 19, 2021
    Point of view on "a selective antibiotic for Lyme disease." Borrelia burgdorferi, a bacterial spirochete, causes Lyme disease. Doxycycline, amoxicillin, and ceftriaxone are broad-spectrum antibiotics ...
    Read More
    Ticks and the Diseases They Cause in the U.S.
    May 15, 2021
    When it comes to transmitting infectious agents to humans, few vectors are as efficient as ticks, the parasitic cousins of spiders. The diversity of pathogens carried by ticks, from bacteria and virus...
    Read More
    Lyme Disease Incidence: Even Greater Than Thought
    February 5, 2021
    POV by Timothy J. Sellati, Ph.D., Chief Scientific Officer, GLA How many people get Lyme disease every year? Precisely determining an annual incidence has been a challenge. Based upon a surveillance r...
    Read More
    How Our Body ‘Sees’ Spirochetes Has Implications for Lyme Disease Severity and Novel Treatments
    December 20, 2020
    by Timothy J. Sellati, Ph.D., Chief Scientific Officer, GLA
    Read More
    When Interpretation of Results Misses the Bull’s-eye
    November 14, 2020
    by Timothy J. Sellati, Ph.D., Chief Scientific Officer, GLA
    Read More
    The need for an alternative to current antibody-based Lyme disease diagnostic tests
    August 25, 2020
    by Timothy J. Sellati, Ph.D., Chief Scientific Officer, Global Lyme Alliance
    Read More
    Do we need clinical trials, even for long-used drugs?
    July 21, 2020
    With the need for fast treatment options, for COVID-19 and other diseases, is it necessary to re-approve drugs already approved by the FDA? by Timothy J. Sellati, Ph.D., Chief Scientific Officer, Glob...
    Read More
    Is the Clinical Trials Process Working?
    June 25, 2020
    GLA’s Chief Scientific Officer takes an important look at our current clinical trials process. Is it still working? Does it serve patient needs?
    Read More
    Research Sharing: What Can Lyme Disease Learn from Skin Cancer?
    May 6, 2020
    Is it possible to leverage research findings and treatment options for malignant cancers, like skin cancer, for Lyme disease?
    Read More
    Parallel Pandemics: COVID-19 and Lyme Disease
    April 2, 2020
    Are there connections between COVID-19 and Lyme disease? by Timothy J. Sellati, Chief Scientific Officer, GLA
    Read More
    GLA Point of View on New Tick-Borne Co-infection Diagnostic Test
    June 12, 2018
    by Timothy Sellati, Ph.D., Chief Scientific Officer, GLA
    Read More
    VIEW MORE

    We need some information
    GLA
    Global Lyme Alliance
    PO Box 25495
    New York, NY 10087-5495

    2023 © Copyright Global Lyme Alliance. All rights reserved.

    Disclaimer: The above material is provided for information purposes only. The material (a) is not nor should be considered, or used as a substitute for, medical advice, diagnosis, or treatment, nor (b) does it necessarily represent endorsement by or an official position of Global Lyme Alliance, Inc. or any of its directors, officers, advisors or volunteers. Advice on the testing, treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient’s medical history. Global Lyme Alliance, Inc. makes no warranties of any kind regarding this Website, including as to the accuracy, completeness, currency or reliability of any information contained herein, and all such warranties are expressly disclaimed.